The results displayed that in glioma, the high expression of SLC35C1 was mainly concentrated in TNFA_SIGNALING_VIA_NFKB, GLYCOLYSIS, APICAL_JUNCTION and other signaling pathways (Fig. 9A). The gene discussed is NFKB1; the disease is central nervous system cancer.